MSH|^~\&|LAB|ARH|||201912161228||ORU^R01|4129416|D|2.3|||AL|NE
PID|1||AB00007953|AB7905|LABTEST^ABBY^|||F||||||||||AB000026/19|
OBR|1|36744^LAB|00027863^1612:C00004R^LAB^161219:C4^36744|522.1390^PROG17^17-alpha-hydroxyprogesterone^^^XXX-0791||201912161019|201912161019|||||||201912161019||||||||||LAB|F||||
OBX|1|ST|522.1400^PROG17 R^17-alpha-hydroxyprogesterone^^X500^XXX-0791|1|10.0^^Y|nmol/L||N||A^S|F|||201912161228
NTE|1||17-OH progesterone reference ranges:
NTE|2||F/M    15D- 1Y            <3.4 nmol/L
NTE|3||F/M    1-7Y               <1.0 nmol/L
NTE|4||F/M    Prepubertal        <1.0 nmol/L
NTE|5||M      17-100y            <6.0 nmol/L
NTE|6||
NTE|7||F      Follicular         <2.4 nmol/L
NTE|8||F      Luteal             <8.6 nmol/L
NTE|9||F      Post-Menopausal    <1.5 nmol/L
OBR|2|36744^LAB|00027863^1612:C00004R^LAB^161219:C4^36744|522.2290^ANDROS^Androstenedione^^^XXX-0712||201912161019|201912161019|||||||201912161019||||||||||LAB|F||||
OBX|1|ST|522.2300^ANDROS R^Androstenedione^^X500^XXX-0712|1|20.000^^Y|nmol/L||N||A^S|F|||201912161113
NTE|1||Androstenedione reference ranges:
NTE|2||Female/Male:
NTE|3||<14D               <2.54 nmol/L
NTE|4||14D-365D           <5.7 nmol/L
NTE|5||1-5Y               <0.568 nmol/L
NTE|6||6-9Y               <0.917 nmol/L
NTE|7||10-11Y             <2.54 nmol/L
NTE|8||
NTE|9||Female:
NTE|10||12-14Y             0.74-6.01 nmol/L
NTE|11||15-18Y             0.48-6.45 nmol/L
NTE|12||>18Y Pre-menopausal 0.91-7.47 nmol/L
NTE|13||     Post-menopausal 0.45-2.86 nmol/L
NTE|14||
NTE|15||Male:
NTE|16||12-14Y             0.51-2.01 nmol/L
NTE|17||15-18Y             0.87-3.55 nmol/L
NTE|18||>18Y               0.80-3.11 nmol/L